SNC-Lavalin Group Inc. (TSE:ATR – Free Report) – Research analysts at Scotiabank upped their FY2026 EPS estimates for shares of SNC-Lavalin Group in a note issued to investors on Wednesday, November 11th. Scotiabank analyst J. Goldman now anticipates that the company will post earnings of $4.00 per share for the year, up from their prior forecast of $3.93. Scotiabank also issued estimates for SNC-Lavalin Group’s FY2027 earnings at $4.59 EPS.
SNC-Lavalin Group Stock Performance
SNC-Lavalin Group Company Profile
AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions.
See Also
- Five stocks we like better than SNC-Lavalin Group
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Receive News & Ratings for SNC-Lavalin Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SNC-Lavalin Group and related companies with MarketBeat.com's FREE daily email newsletter.
